| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.0M | — | -6.3% |
| Cost of Revenue | $3.1M | — | -22.7% |
| Gross Profit | $2.9M | — | +22.1% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $2.1M | — | -7.1% |
| Operating Income | $408K | — | +1021.8% |
| Pre-tax Income | $314K | — |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.9M | -19.8% | -49.0% |
| Accounts Receivable | $41K | +65.3% | -95.5% |
| Current Assets | $23.3M | -34.4% | -52.2% |
| Total Assets | $30.1M | -28.1% | -45.7% |
| Current Liabilities | $21.4M | -19.3% | -46.2% |
| Total Liabilities |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $386K | — | -95.0% |
| Investing Cash Flow | $623K | — | +6.2% |
| Financing Cash Flow | -$6.7M | — | -799.5% |
| -62.3% |
| Net Income | $293K | — | -64.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $22.4M |
| -18.3% |
| -44.5% |
| Stockholders' Equity | $7.7M | -46.9% | -48.9% |